Updated 9/11/18. The results chart includes audits where the findings have been finalized. Remaining audits are still under review. Information on Corrective Action Plans and Sanctions will be updated once approved by HRSA. HRSA recommends covered entities do not contact audited manufacturers regarding sanctions until a corrective action plan has been approved by HRSA and posted on this website.
Results posted for 5 audits.
| Manufacturer | Labeler Codes Reviewed | State | OPA Findings | Sanction | Corrective Action Status | Manufacturer Contact Information |
|---|---|---|---|---|---|---|
| Biogen U.S. Corp. | 59627 64406 |
MA | No adverse findings | None | N/A | |
| EMD Serono, Inc. | 44087 | MA | No adverse findings | None | N/A | |
| Jacksonville Pharmaceuticals, Inc. | 70003 | FL | No adverse findings | None | N/A | |
| Pharmacyclics, LLC | 57962 | CA | No adverse findings | None | N/A | |
| Shire US, Inc. | 42227 47783 59417 54092 58521 66593 68875 64193 00944 |
PA | No adverse findings | None | N/A |
